These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6251790)

  • 1. In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.
    Sorensen O; Perry D; Dales S
    Arch Neurol; 1980 Aug; 37(8):478-84. PubMed ID: 6251790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus.
    Sorensen O; Saravani A; Dales S
    Microb Pathog; 1987 Feb; 2(2):79-90. PubMed ID: 2853273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease.
    Morris VL; Tieszer C; Mackinnon J; Percy D
    Virology; 1989 Mar; 169(1):127-36. PubMed ID: 2538027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro models of demyelinating disease, XXIII: Infection by JHM virus of athymic rats.
    Sorensen O; Saravani A; Dales S
    Adv Exp Med Biol; 1987; 218():383-90. PubMed ID: 2829549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.
    Sorensen O; Dugre R; Percy D; Dales S
    Infect Immun; 1982 Sep; 37(3):1248-60. PubMed ID: 6290393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JHM infections in rats as a model for acute and subacute demyelinating disease.
    Wege H; Koga M; Wege H; ter Meulen V
    Adv Exp Med Biol; 1981; 142():327-40. PubMed ID: 6278889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late CNS-effects of corona virus infection in rats.
    Nagashima K; Wege H; ter Meulen V
    Adv Exp Med Biol; 1978; 100():395-409. PubMed ID: 211826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin F attenuates neuroinflammation and demyelination following murine coronavirus infection of the central nervous system.
    Syage AR; Pachow C; Murray KM; Henningfield C; Fernandez K; Du A; Cheng Y; Olivarria G; Kawauchi S; MacGregor GR; Green KN; Lane TE
    J Neuroinflammation; 2024 Jun; 21(1):157. PubMed ID: 38879499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial Inoculation Is More Potent Than Intranasal Inoculation for Inducing Optic Neuritis in the Mouse Hepatitis Virus-Induced Model of Multiple Sclerosis.
    Singh M; Khan RS; Dine K; Das Sarma J; Shindler KS
    Front Cell Infect Microbiol; 2018; 8():311. PubMed ID: 30234031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.
    Sorensen O; Coulter-Mackie MB; Puchalski S; Dales S
    Virology; 1984 Sep; 137(2):347-57. PubMed ID: 6091333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice.
    Knobler RL; Tunison LA; Lampert PW; Oldstone MB
    Am J Pathol; 1982 Nov; 109(2):157-68. PubMed ID: 6291396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic central nervous system demyelination in mice after JHM virus infection.
    Stohlman SA; Weiner LP
    Neurology; 1981 Jan; 31(1):38-44. PubMed ID: 6256683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasoencephalopathy of mice infected intrananasally with a mouse hepatitis virus, JHM strain.
    Goto N; Hirano N; Aiuchi M; Hayashi T; Fujiwara K
    Jpn J Exp Med; 1977 Feb; 47(1):59-70. PubMed ID: 192927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of CD8+ T cells and viral spread to demyelinating disease.
    Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
    J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro models of demyelinating diseases.
    Sorensen O; Coulter-Mackie M; Percy D; Dales S
    Adv Exp Med Biol; 1981; 142():271-86. PubMed ID: 6278886
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of immune and central nervous systems: contribution of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM.
    Fleming JO; Wang FI; Trousdale MD; Hinton DR; Stohlman SA
    Reg Immunol; 1993; 5(1):37-43. PubMed ID: 8102242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination.
    Wang FI; Hinton DR; Gilmore W; Trousdale MD; Fleming JO
    Lab Invest; 1992 Jun; 66(6):744-54. PubMed ID: 1318460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate receptor antagonism enhances proliferation and migration of engrafted neural progenitor cells in a model of viral-induced demyelination.
    Blanc CA; Grist JJ; Rosen H; Sears-Kraxberger I; Steward O; Lane TE
    Am J Pathol; 2015 Oct; 185(10):2819-32. PubMed ID: 26435414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy.
    Sorensen O; Dales S
    J Virol; 1985 Nov; 56(2):434-8. PubMed ID: 2997466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of JHM central nervous system infections in rats.
    Parham D; Tereba A; Talbot PJ; Jackson DP; Morris VL
    Arch Neurol; 1986 Jul; 43(7):702-8. PubMed ID: 3015091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.